- Home
- ASTI vs QNRX Comparison
ASTI vs QNRX Comparison
Compare ASTI & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- QNRX
- Stock Information
- Founded
- ASTI 2005
- QNRX 2018
- Country
- ASTI United States
- QNRX United States
- Employees
- ASTI N/A
- QNRX N/A
- Industry
- ASTI Semiconductors
- QNRX Medical/Dental Instruments
- Sector
- ASTI Technology
- QNRX Health Care
- Exchange
- ASTI Nasdaq
- QNRX Nasdaq
- Market Cap
- ASTI 2.9M
- QNRX 3.3M
- IPO Year
- ASTI N/A
- QNRX N/A
- Fundamental
- Price
- ASTI $1.62
- QNRX $8.82
- Analyst Decision
- ASTI
- QNRX
- Analyst Count
- ASTI 0
- QNRX 0
- Target Price
- ASTI N/A
- QNRX N/A
- AVG Volume (30 Days)
- ASTI 40.2K
- QNRX 522.9K
- Earning Date
- ASTI 08-05-2025
- QNRX 05-13-2025
- Dividend Yield
- ASTI N/A
- QNRX N/A
- EPS Growth
- ASTI N/A
- QNRX N/A
- EPS
- ASTI N/A
- QNRX N/A
- Revenue
- ASTI $51,917.00
- QNRX N/A
- Revenue This Year
- ASTI N/A
- QNRX N/A
- Revenue Next Year
- ASTI N/A
- QNRX N/A
- P/E Ratio
- ASTI N/A
- QNRX N/A
- Revenue Growth
- ASTI N/A
- QNRX N/A
- 52 Week Low
- ASTI $1.17
- QNRX $5.01
- 52 Week High
- ASTI $14.18
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- ASTI 46.50
- QNRX 57.93
- Support Level
- ASTI $1.54
- QNRX $8.67
- Resistance Level
- ASTI $1.77
- QNRX $9.30
- Average True Range (ATR)
- ASTI 0.11
- QNRX 0.62
- MACD
- ASTI -0.01
- QNRX 0.03
- Stochastic Oscillator
- ASTI 22.86
- QNRX 56.63
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.